CTI BIOPHARMA CORP
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for CTI BIOPHARMA CORP COM, CUSIP 12648l106.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for CTI BIOPHARMA CORP COM, CUSIP 12648l106.